The group’s principle activity is to provide drug delivery technologies to commercialize specialty pharmaceutical products and to provide delivery solutions for drugs. The group’s product pipeline includes Lip'ral, Lip'ral-SSR, Hydroance and Nanosplode. The group’s technologies utilize lipidic multiphase systems to meet varied range of therapeutic needs and market opportunities. The group operates from United States.
